Biblio Discovery — Demo Discovery Service

35 results for "Francesco Autore"

Showing 1–20 · 0.26 seconds · RSS

  1. Journal Article

    Morphological, immunophenotypic, and genetic features of chronic lymphocytic leukemia with trisomy 12: a comprehensive review

    Francesco Autore; Paolo Strati; Luca Laurenti et al.

    Haematologica, Vol. 103 No. 6 · 2018 · English · DOAJ Scopus

    Chronic lymphocytic leukemia is an extremely heterogeneous disease and prognostic factors such as chromosomal abnormalities are important predictors of time to first treatment and survival. Trisomy 12 is the second most frequent aberration detected by fluorescence in situ hybridization at the time…

  2. Journal Article Full text

    Chronic Myeloid Leukemia in a Patient with Previous Idiopathic Thrombocytopenic Purpura: How to Manage Imatinib Together with Eltrombopag

    Francesco Autore; Federica Sora’; Patrizia Chiusolo et al.

    Medicina, Vol. 57 No. 12 · 2021 · English · DOAJ Scopus

    The occurrence of chronic myeloid leukemia (CML), or other myeloproliferative diseases, after the development of idiopathic thrombocytopenic purpura (ITP) is very rare in the current medical literature. Considering the advances in ITP management, and the wide use of new drugs for ITP and CML, we…

  3. Journal Article Full text

    Successful Second Autologous Stem Cell Transplantation for Late Disease Progression after the First Procedure in POEMS Syndrome

    Francesco Autore; Idanna Innocenti; Federica Sora et al.

    Applied Sciences, Vol. 12 No. 5 · 2022 · English · DOAJ Scopus

    Autologous stem cell transplantation (ASCT) is a good option in fit young patients affected by POEMS syndrome. Few data are published on how to treat these patients in case of relapse. In this paper we described our two patients who underwent a second ASCT. From our experience, we can confirm that…

  4. Journal Article

    Measurable residual disease in chronic lymphocytic leukemia

    Giulia Benintende; Federico Pozzo; Idanna Innocenti et al.

    Frontiers in Oncology, Vol. 13 · 2023 · English · DOAJ Scopus

    Measurable residual disease (MRD) is defined as the presence of residual cancer cells after treatment in patients with clinically undetectable disease, who would otherwise be considered in complete remission. It is a highly sensitive parameter which indicates the disease burden and predicts…

  5. Journal Article

    IS ALLOGENEIC TRANPLANTATION AN OPTION IN PATIENTS AFFECTED BY CONCURRENT MYELOFIBROSIS AND CHRONIC MYELOID LEUKEMIA (CML)?

    Federica Sorà; Patrizia Chiusolo; Francesco autore et al.

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 13 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Classification of myeloproliferative neoplasms is based on hematologic, histopathologic and molecular characteristics including the presence of the BCR-ABL1 and JAK2 V617F or MPL and CALR. Although the different gene mutations ought to be mutually exclusive, a number of cases with…

  6. Journal Article Full text

    DAYS ALIVE OUTSIDE HOSPITAL AND RE-ADMISSIONS IN PATIENTS UNDERGOING ALLOGENEIC TRANSPLANTS FROM IDENTICAL SIBLINGS, UNRELATED DONORS OR HAPLOIDENTICAL DONORS “.

    Federica Sorà; patrizia chiusolo; luca laurenti et al.

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 12 No. 1 · 2020 · English · DOAJ Scopus

    We have studied the number of days alive outside Hospital (DAOH) and the number of re-admissions within the first 100 days after transplant in 185 patients who received an allogeneic hemopoietic stem cell transplant (HSCT). The donors were matched siblings (SIB; n=61), or alternative donors (ALT…

    Also available at: DOAJ

  7. Journal Article

    VEGF and IL-6 correlation in POEMS: a potential upcoming marker of active disease and early autologous BMT response.

    Luca Laurenti; Idanna Innocenti; Giulia Benintende et al.

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 14 No. 1 · 2022 · English · DOAJ Scopus

    Introduction: VEGF function may be responsible for most POEMS manifestations, and it is considered a reliable marker of disease. COVID-19 era arose increasing interest for other inflammatory cytokines, with particular focus on Interleukin-6; VEGF production is stimulated by IL-6 and IL1β, whose…

  8. Journal Article

    CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.

    Luca Laurenti; Barbara Vannata; Idanna Innocenti et al.

    Mediterranean Journal of Hematology and Infectious Diseases, Vol. 5 No. 1 · 2013 · English · DOAJ Scopus

    Currently standard first line therapy for fit patients with B-CLL/SLL are fludarabine-based regimens. Elderly patients or patients with comorbidities poorly tolerate purine analogue-based chemotherapy and they are often treated with Chlorambucil (Chl). However, complete response (CR) and overall…

  9. Journal Article

    Efficacy and Tolerability of First Line Arsenic Trioxide in Combination With All-Trans Retinoic Acid in Patients With Acute Promyelocytic Leukemia: Real Life Experience

    Francesco Autore; Patrizia Chiusolo; Federica Sorà et al.

    Frontiers in Oncology, Vol. 11 · 2021 · English · DOAJ Scopus

    Acute promyelocytic leukemia is a variant of acute myeloid leukemia characterized by t(15;17) and PML/RAR alfa fusion gene. The discovery of the molecular pathogenesis has led to entitle all-trans retinoic acid (ATRA) as the first targeted therapy for acute leukemia. It is usually associated to…